Genome-based risk prediction of asthma and COPD: applicability and psychological issues

C. Janssens (Rotterdam, Netherlands)

Source: Annual Congress 2012 - Genetics and genomics in asthma and COPD: prediction and personalised medicine
Disease area: Airway diseases

Slide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Janssens (Rotterdam, Netherlands). Genome-based risk prediction of asthma and COPD: applicability and psychological issues. Annual Congress 2012 - Genetics and genomics in asthma and COPD: prediction and personalised medicine

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Recognising and addressing the psychosocial and behavioural aspects of COPD and asthma patients
Source: Annual Congress 2004 - Psychosocial and behavioural aspects of chronic respiratory diseases
Year: 2004

Comparison of multidimensional assessment systems with regard to risk prediction for exacerbations of COPD
Source: Annual Congress 2011 - COPD exacerbation
Year: 2011

External validation of exacerbation and mortality outcomes of health economic decision models for COPD
Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD
Year: 2016

The further paradoxes of asthma management: time for a new approach across the spectrum of asthma severity
Source: Eur Respir J, 52 (5) 1800694; 10.1183/13993003.00694-2018
Year: 2018



A new perspective on COPD exacerbations: monitoring impact by measuring physical, psychological and social resilience
Source: Eur Respir J 2016; 47: 1024-1027
Year: 2016


An innovative risk score for prediction of asthma related adverse outcome
Source: Annual Congress 2009 - Quality of treatment in primary respiratory care
Year: 2009


Complexity in chronic asthma and COPD: implications for risk assessment, disease progression and control
Source: Annual Congress 2008 - A step-change in asthma. The Lancet/ERS symposium
Year: 2008


Avoiding confusion in COPD: from risk factors to phenotypes to measures of disease characterisation
Source: Eur Respir J 2011; 38: 749-751
Year: 2011


Efficiency of different approaches for the assessment of the risk of exacerbations in patients with COPD
Source: International Congress 2019 – Airway disease-associated exacerbations
Year: 2019


What is a COPD exacerbation? Current definitions, pitfalls, challenges and opportunities for improvement
Source: Eur Respir J, 52 (5) 1801261; 10.1183/13993003.01261-2018
Year: 2018



The consequences of different definitions in the prediction of asthma in children
Source: Annual Congress 2008 - Paediatric airway diseases - pathophysiology and monitoring
Year: 2008


COPD: algorithms and clinical management
Source: Eur Respir J, 50 (5) 1701733; 10.1183/13993003.01733-2017
Year: 2017



Socioeconomic outcome of subjects experiencing asthma symptoms at work
Source: Eur Respir J 2002; 19: 1107-1113
Year: 2002



Management of patients with asthma or COPD and cardiovascular disease: risks versus benefits
Source: Eur Respir Monogr 2020; 88: 66-81
Year: 2020


Mathematical model to predict the risk of future exacerbations in non-smoking patients with COPD
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016

Efficiency of different multidimensional indexes for the assessment of the risk of exacerbations in patients with COPD
Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases
Year: 2020


Predicting risk of undiagnosed COPD: development and validation of the TargetCOPD score
Source: Eur Respir J, 49 (6) 1602191; 10.1183/13993003.02191-2016
Year: 2017